Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Integrated Mobile Health-supported Heart Rhythm Management Around Electrical Cardioversion in Terms of Cancelling Unnecessary Scheduled ECV Appointments in Patients With Presumed Persistent Atrial Fibrillation (TeleConvert-AF)

NCT06359132 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT06359132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06359132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Integrated Mobile Health-supported Heart Rhythm Management Around Electrical Cardioversion in Terms of Cancelling Unnecessary Scheduled ECV Appointments in Patients With Presumed Persistent Atrial Fibrillation (TeleConvert-AF)
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
July 1, 2022
Completion date
June 1, 2025
Enrollment
270 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, atrial fibrillation, electrical cardioversion, mobile health